Skip to Content

COVID-19 is an emerging, rapidly evolving situation.

What people with cancer should know: https://www.cancer.gov/coronavirus

Guidance for cancer researchers: https://www.cancer.gov/coronavirus-researchers

Get the latest public health information from CDC: https://www.coronavirus.gov

Get the latest research information from NIH: https://www.nih.gov/coronavirus

Cancer Imaging Program (CIP)
Contact CIP
Show menu
Search this site
Last Updated: 03/26/20

Current Funding Opportunities

CIP Scientific Contact Link to Initiative
Lalitha Shankar, M.D., Ph.D. PA-19-112: Improving Outcomes in Cancer Treatment-Related Cardiotoxicity (R01 Clinical Trial Optional)
Lalitha Shankar, M.D., Ph.D. PA-19-111: Improving Outcomes in Cancer Treatment-Related Cardiotoxicity (R21 Clinical Trial Optional)
Huiming Zhang, Ph.D. PAR-18-841: Oncology Co-Clinical Imaging Research Resources to Encourage Consensus on Quantitative Imaging Methods and Precision Medicine (U24 - Clinical Trial Optional)
Anne Menkens, Ph.D. PAR-18-629: Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional)
Michael McDonald, Ph.D. PAR-18-560: Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
Houston Baker, Ph.D. PAR-18-530: Academic-Industrial Partnerships for Translation of Technologies for Cancer Diagnosis and Treatment (R01)
Keyvan Farahani, Ph.D. PAR-18-252: Image-guided Drug Delivery (R01)
Robert J. Nordstrom, Ph.D. PAR-18-248: Quantitative Imaging Tools and Methods for Cancer Therapy Response Assessment (UG3/UH3)
Lalitha Shankar, M.D., Ph.D. PAR-18-011: Early Phase Clinical Trials in Imaging and Image-Guided Interventions (R01)
Anne Menkens, Ph.D. PAR-18-629: Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional)
Piotr Grodzinski, Ph.D. PAR-20-116: Toward Translation of Nanotechnology Cancer Interventions (TTNCI) (R01 Clinical Trial Not Allowed)
Darrell Tata, Ph.D,
Robert J. Nordstrom, Ph.D.
PAR-18-919: Quantitative Imaging Tools and Methods for Cancer Response Assessment (R01 Clinical Trial Optional)

Scientific Contact Link to Initiative
Yantian Zhang, Ph.D. PA-17-243 - Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R21)
Yantian Zhang, Ph.D. PA-17-239 - Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R01)